Want to join the conversation?
$MRK 2Q15 Q&A: On the question of REMICADE biosimilar by Risinger of Morgan Stanley, Adam told there is no any major impact on products outside of REMICADE. Commenting on cancer conferences on I-O franchise, Roger told a lot of data will be available at AASLD and expect to have the opportunity to present some data with respect to triplet therapy.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.